CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 31 - 40 of 1135
Study Number Lead Group Study Title CIRB Study Status
A212102 Alliance Blinded Reference Set for Multicancer Early Detection Blood Tests Cancer Prevention and Control CIRB Available to Open
A091401 Alliance Randomized Phase II Study Of Nivolumab With Or Without Ipilimumab In Patients With Metastatic Or Unresectable Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
A051901 Alliance Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma Adult CIRB - Early Phase Emphasis Available to Open
A041703 Alliance Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease Adult CIRB - Late Phase Emphasis Available to Open
A092001 Alliance Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or Without Immunotherapy for Peritoneal Mesothelioma Adult CIRB - Late Phase Emphasis Available to Open
A222101 Alliance An Early Phase and Phase II Clinical Trial to Evaluate Ganglioside-Monosialic Acid (GM1) for Preventing Paclitaxel-Associated Neuropathy Cancer Prevention and Control CIRB Available to Open
A011203 Alliance A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women with Metastatic; Estrogen Receptor Positive; HER2 Negative Breast Cancer Adult CIRB - Early Phase Emphasis Available to Open
A231602CD Alliance Assessing Financial Difficulty in Patients with Blood Cancers Cancer Prevention and Control CIRB Available to Open
A091903 Alliance A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma Adult CIRB - Late Phase Emphasis Available to Open
A021602 Alliance Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus (CABINET) Adult CIRB - Late Phase Emphasis Available to Open
Displaying 31 - 40 of 1135